- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Specialises in
- General
- Haemato-oncology
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
Dr Walewska has been a consultant haematologist at the Royal Bournemouth Hospital since 2010. She qualified in Sheffield and completed her specialist haematology training in Leicester where also she completed a PhD in identifying and characterising novel markers in CLL. She is an active member of the UK CLL Forum and is part of the writing committee that recently updated the national BSH CLL guidelines, since March 2019 she is chairing UK CLL Forum. She is an invited clinical advisor to the Evidence Review Group for NICE appraisals. In addition to CLL, she has developed an interest in Splenic Marginal Zone Lymphoma. RW is a member of the NCRI CLL Low Grade NHL subgroup and also collaborates internationally with colleagues developing trials in SMZL. She remains active in scientific research and holds an honorary contract with Southampton University.
Areas of interest
chronic lymphocytic leukaemia, low grade lymphomas, high grade lymphomas
Medical secretaries
- Bournemouth Private Clinic
- Royal Bournemouth Hospital Castle Lane East BOURNEMOUTH BH7 7DW
- 0300 019 4992
- privatehealth@uhb.nhs.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
-
AD979
ibrutinib (Imbruvica) 420mg tablets x 28 - (5-50)
-
AD913
Venetoclax (Venclyxto) 112 x 100mg tablets - (1-5)
-
X3590
Intravenous infusion (as sole procedure) - (1-5)